By pursuing excellence in research, IBS has selected global leading scientists as directors of Centers. These directors are operating 31 Centers of which research proposals are evaluated superior in the IBS peer review process. The review is carried out by a Review Panel composed of independent and expert scientists from Korea and abroad. Directors choose the themes of their research and allocate funds accordingly. Generally, Centers operate projects with no fixed term for their duration as long as the quality of research is verified in evaluations. New Centers receive an initial evaluation five years after its launch, followed by three-year interval evaluations. IBS has been inviting top scientists from around the globe and providing them full support for their relocations. Young scientists also enjoy unique research opportunities to collaborate with world renowned scientists and to organize and operate their own research groups, broadening their professional expertise. IBS brings together outstanding talents throughout all career levels to grow and inspire each other through close collaborations.
We're tracking Institute For Basic Science (IBS)'s market expansion
1 signal in the last 90 days.
How Institute For Basic Science (IBS)'s international expansion compares to its competitors
Institute For Basic Science (IBS)YouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Institute For Basic Science (IBS)You | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Yemi Lab, a 1000m underground research facility in Jeongseon, conducts cosmic research while fostering local science education and community development.
IBS hosts 3rd Brain Science Camp for high school students, offering hands-on experience in neuroscience research and career exploration.
IBS researchers developed 'CDr17', a fluorescent molecule that selectively detects M1 macrophages, potentially improving diagnosis of autoimmune diseases like rheumatoid arthritis.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Institute For Basic Science (IBS)'s business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
